Cargando…
Inhaled dry powder alginate oligosaccharide in cystic fibrosis: a randomised, double-blind, placebo-controlled, crossover phase 2b study
BACKGROUND: OligoG is a low molecular-weight alginate oligosaccharide that improves the viscoelastic properties of cystic fibrosis (CF) mucus and disrupts biofilms, thereby potentiating the activity of antimicrobial agents. The efficacy of inhaled OligoG was evaluated in adult patients with CF. METH...
Autores principales: | van Koningsbruggen-Rietschel, Silke, Davies, Jane C., Pressler, Tacjana, Fischer, Rainald, MacGregor, Gordon, Donaldson, Scott H., Smerud, Knut, Meland, Nils, Mortensen, Jann, Fosbøl, Marie Ø., Downey, Damian G., Myrset, Astrid H., Flaten, Hugo, Rye, Philip D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569163/ https://www.ncbi.nlm.nih.gov/pubmed/33123558 http://dx.doi.org/10.1183/23120541.00132-2020 |
Ejemplares similares
-
Getting Near to “Closing the Gap” in the Pediatric Age
Group for the First Personalized Treatment of Cystic Fibrosis
por: van Koningsbruggen-Rietschel, Silke
Publicado: (2021) -
SARS-CoV-2 disrupts clinical research: the role of a rare disease-specific trial network
por: van Koningsbruggen-Rietschel, Silke, et al.
Publicado: (2020) -
Review of recombinant human deoxyribonuclease (rhDNase) in the management of patients with cystic fibrosis
por: Pressler, Tacjana
Publicado: (2008) -
Alginate oligosaccharides enhance diffusion and activity of colistin in a mucin-rich environment
por: Stokniene, Joana, et al.
Publicado: (2022) -
Advances in Research on the Bioactivity of Alginate Oligosaccharides
por: Xing, Maochen, et al.
Publicado: (2020)